AIFF Company Profile and Key Details

Short-term trend indicators are bullishly aligned (SMA20 -8.4%, SMA50 -28.01%, SMA200 -68.67%). The stock’s 14-day RSI is 33.68 (weak momentum), while the ATR of 0.06 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -88.57% below its high and over 11.98% above its low. Average 10-day trading volume of 2.00 million shares is significantly above the 3-month average of 315.02 thousand, indicating heightened recent market interest.

Firefly Neuroscience, Inc. has 15.69 million shares outstanding. The public float is 14.02 million shares, elevated short interest at 2.85% of float. This equals 422.22 thousand shares. The short ratio is 3.51 days. Institutional investors hold 10.96% of the float. Insiders own 28.28%.

Firefly Neuroscience, Inc. generated EPS of -$2.53 over the past year. Five-year average earnings growth is 3.61%.

Firefly Neuroscience, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.32. This means the shares are trading below this model’s fair value.

Firefly Neuroscience, Inc. (NASDAQ:AIFF) closed at $2.01 USD, gaining $0.82 (68.91%) from the previous close of $1.19. The stock is currently mid-range between its 52-week high and low $0.62 and $3.15. With a market capitalization of about $29.73 million, Firefly Neuroscience, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~0.57). Key stats such as the average daily volume over the past year has been around 317.18 thousand shares, trading with heavier-than-usual volume. Headquartered in Kenmore, NY, Firefly Neuroscience, Inc. operates in the Technology sector and the Software - Application industry. Led by CEO Greg Lipschitz, the company employs approximately 17 people and listed since November 28, 2002. Based in Toronto, Canada, Firefly Neuroscience, Inc. is a medical technology and artificial intelligence firm specializing in developing neuroscientific solutions.

Firefly Neuroscience, Inc. trades at a P/E ratio of -2.74, slightly below the S&P 500 average, with a price-to-sales ratio of 14.34 and a price-to-book ratio of 2.45 suggesting the stock is closer to book value. The P/FCF stands at -3.58, also below market averages.

Firefly Neuroscience, Inc. (NASDAQ:AIFF) shares are up 13.29% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Firefly Neuroscience, Inc. trading at a premium to the broader market with a P/E of -2.74. Our AI forecast model points to short-term strength (1.68% over two weeks), a medium-term fall (-81.51% over three months), and a longer-term loss (-15.97% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Firefly Neuroscience, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 1.68%, with price expected at $1.21 by October 08, 2026, within a range of $1.14 to $1.28 3-Month Outlook: Projected fall of -81.51%, reaching $0.22 by December 23, 2026, with a range of $0.07 to $0.36. 1-Year Outlook: Projected loss of -15.97%, with price at $1.00 by September 24, 2027, within a range of $0.00 to $0.63.